| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $29.0M | -44.4% |
| SG&A Expense | $13.6M | -28.1% |
| Operating Income | -$42.6M | +42.1% |
| Pre-tax Income | -$40.2M | +38.6% |
| Net Income | -$40.2M | +38.6% |
| EPS (Basic) | -$1.89 | +39.2% |
| EPS (Diluted) | -$1.89 | +39.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.8M | +9.6% |
| Short-term Investments | $0 | -100.0% |
| Current Assets | $14.7M | -73.7% |
| Total Assets | $18.2M | -69.3% |
| Current Liabilities | $5.6M | -38.8% |
| Total Liabilities | $7.0M | -39.8% |
| Stockholders' Equity | $11.2M | -76.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$40.5M | +32.1% |
| Investing Cash Flow | $41.5M | +202.3% |
| Financing Cash Flow | $114K | -59.3% |